[Metabolic syndrome in dialyzed patients. Diagnosis and insulin resistance].
The criteria for diagnosis of metabolic syndrome (MeS) in patients treated with intermittent hemodialysis or peritoneal dialysis are presented in the paper. Metabolic syndrome is diagnosed in more than 60% of dialyzed patients, but components of MeS, especially hypertension, are much more frequently, also in patients in whom there is no basis for the diagnosis. Increased insulin resistance is a symptom, that in dialysis patients is associated with loss of muscle mass. This is one of the causes of protein malnutrition, despite the concomitant determined abdominal obesity.
Grzegorzewska
Alicja E
AE
Uniwersytet Medyczny w Poznaniu, Katedra i Klinika Nefrologii, Transplantologii i Chorób Wewnetrznych. alicja_grzegorzewska@yahoo.com
D006801:Humans; D007333:Insulin Resistance; D024821:Metabolic Syndrome / Q000175:diagnosis* / Q000209:etiology*; D018908:Muscle Weakness / Q000209:etiology / Q000503:physiopathology; D010530:Peritoneal Dialysis / Q000009:adverse effects*; D011502:Protein-Energy Malnutrition / Q000209:etiology* / Q000503:physiopathology; D006435:Renal Dialysis / Q000009:adverse effects*